Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Rubin

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1993
Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivoD L Rubin, H H Muller, M K Sidhu, et al.
Investigative Radiology|April 1, 1995
Influence of viscosity on WIN 39996 as a contrast agent for gastrointestinal magnetic resonance imagingD L Rubin, H H Muller, S W Young, et al.
Methods of Information in Medicine|May 14, 2013
Formative evaluation of ontology learning methods for entity discovery by using existing ontologies as reference standardsK Liu, K J Mitchell, W W Chapman, et al.
AJR. American Journal of Roentgenology|August 3, 1999
Safety and efficacy of a new oral contrast agent for sonography: a phase II trialA S Lev-Toaff, J E Langer, D L Rubin, et al.
Investigative Radiology|June 1, 1994
Nanoparticulate contrast media. Blood-pool and liver-spleen imagingD L Rubin, T S Desser, F Qing, et al.
Radiology|March 1, 1997
Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227M G Harisinghani, S Saini, R Weissleder, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 1, 1994
Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weightT S Desser, D L Rubin, H H Muller, et al.
Investigative Radiology|June 1, 1994
Quantitation of saturation effects versus dose in three-dimensional time-of-flight magnetic resonance angiography with blood-pool contrast agentsT S Desser, D L Rubin, Q Fan, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 17, 1999
A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trialD L Rubin, T S Desser, R Semelka, et al.
The Pharmacogenomics Journal|March 23, 2002
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge BaseT E Klein, J T Chang, M K Cho, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1993
Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivoD L Rubin, H H Muller, M K Sidhu, et al.
Investigative Radiology|April 1, 1995
Influence of viscosity on WIN 39996 as a contrast agent for gastrointestinal magnetic resonance imagingD L Rubin, H H Muller, S W Young, et al.
Methods of Information in Medicine|May 14, 2013
Formative evaluation of ontology learning methods for entity discovery by using existing ontologies as reference standardsK Liu, K J Mitchell, W W Chapman, et al.
AJR. American Journal of Roentgenology|August 3, 1999
Safety and efficacy of a new oral contrast agent for sonography: a phase II trialA S Lev-Toaff, J E Langer, D L Rubin, et al.
Investigative Radiology|June 1, 1994
Nanoparticulate contrast media. Blood-pool and liver-spleen imagingD L Rubin, T S Desser, F Qing, et al.
Radiology|March 1, 1997
Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227M G Harisinghani, S Saini, R Weissleder, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 1, 1994
Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weightT S Desser, D L Rubin, H H Muller, et al.
Investigative Radiology|June 1, 1994
Quantitation of saturation effects versus dose in three-dimensional time-of-flight magnetic resonance angiography with blood-pool contrast agentsT S Desser, D L Rubin, Q Fan, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 17, 1999
A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trialD L Rubin, T S Desser, R Semelka, et al.
The Pharmacogenomics Journal|March 23, 2002
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge BaseT E Klein, J T Chang, M K Cho, et al.
Pageof 6